Value of N-Terminal Pro B-Type Natriuretic Peptide,High-Sensitivity C-Reactive Protein,and Homocysteine Levels in Predicting Cardiovascular Events in Chronic Heart Failure Patients After Discharge

作     者：Qian Yu Linya Zhao Yinyin Chen Qing Zhao 

作者机构：Affiliated Hospital of Hebei UniversityBaoding 071000Hebei ProvinceChina 

出 版 物：《Proceedings of Anticancer Research》 (抗癌研究)

年 卷 期：2023年第7卷第2期

页      面：22-27页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：supported by the Project of Baoding Science and Technology Bureau(Project number:2241ZF343) 

主　　题：Chronic heart failure N-terminal pro B-type natriuretic peptide Homocysteine High-sensitivity C-reactive protein 

摘      要：Objective:To investigate the value of N-terminal pro B-type natriuretic peptide(NT-proBNP),high-sensitivity C-reactive protein(hs-CRP),and homocysteine(Hcy)levels in predicting cardiovascular events(CV)in patients with chronic heart failure(CHF).Methods:A total of 63 patients with CHF admitted to our hospital between June 2019 and July 2021 were *** NT-proBNP,hs-CRP,and Hcy levels were detected at discharge,and a 12-month follow-up was done after their discharge to collect clinical *** collected data were inclusive of data from 21 CHF patients with cardiovascular disease and 42 CHF patients without cardiovascular *** effect of NT-proBNP,hs-CRP,and Hcy levels on the occurrence of CV was ***:The levels of NT-proBNP,hs-CRP,and Hcy in the group with cardiovascular disease were significantly higher than those in the group without cardiovascular disease(P0.05);the levels of serum NT-proBNP,hs-CRP,and Hcy at discharge had certain value in predicting short-term CV in CHF patients(P0.05).Conclusion:NT-proBNP,hs-CRP,and Hcy levels can be used to predict CV in CHF patients,thus having clinical application value.